Morphology-based cytogenetic risk prediction in multiple myeloma from bone marrow smears
Cytogenetic abnormalities determine prognosis and treatment selection in multiple myeloma (MM). However, genetic testing via fluorescence in situ hybridization remains expensive and inaccessible in many clinical settings. Prior studies have established that specific chromosomal alterations correlate...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2026-03-01
|
| Edice: | Frontiers in Oncology |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1790130/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
